A new study found the drug to effectively improve survival among severely sick Covid-19 patients.
Sutaria noted that new Covid-19 patients in markets where cases are rising tend to be younger, in their mid-30s to mid-60s, and require less intensive care treatment.Homebuilder sentiment surges, showing a rebound from lockdown "As the nation reopens, housing is well-positioned to lead the economy forward," said NAHB Chairman Dean Mon, a homebuilder and developer from Shrewsbury, New Jersey. "Inventory is tight, mortgage applications are increasing, interest rates are low and confidence is rising.
and the three may be rolled as vaccinations in a few months. Gilead, Moderna, and CanSino. They are all finishing up phase III trials with Gilead already on its way in Singapore. It helps patients on ventilators as well as mild symptoms with NO side effects.
WRONG. Wonderful news for patients on ventilators ONLY. Dexamethasone does not appear to help people with milder symptoms of coronavirus who do not need help with their breathing. There are still three treatments pending one already in use in Singapore with great efficacy.
Might want to give him time to read the study. There have been some walk backs after questionable data
Cheap plastic bottled whiskey has the same impact.
Since he’s a Gottleib I’m wondering if he stole these results from someone else.
Herd immunity is cheaper and more effective
Steroids were bad for covid19 patients and now suddenly it’s good. Guess why? Need for positive news.